Study to Evaluate TV-46000 as Maintenance Treatment in Participants With Schizophrenia
- Study Title
- Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia
- Teva Identifier
- TV46000-CNS-30072 | 03503318 | 2018-001619-65
- ClinicalTrials.gov Identifier
- NCT03503318
- Study Status
- Completed
- Trial Condition(s)
- Schizophrenia
- Interventions
- Drug: TV-46000 - A | Drug: TV-46000 - B | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 13 Years to 65 Years
- Trial Duration
- April 27, 2018 - December 3, 2020
- Phase
- Phase 3
